Related Experiment Videos
Clinical features of nodular paragranuloma (Hodgkin's disease, lymphocyte predominance type, nodular)
Abstract:
Clinical aspects of 145 cases of nodular paragranuloma (nodular subtype of lymphocyte predominance type of Hodgkin's disease) were investigated. There was a marked male predominance, and the age curve showed a peak in the 4th decade. In a majority of cases lymphadenopathy developed within 1 year. General (B) symptoms were observed in only 15 patients. The most frequent sites of primary involvement were cervical, axillary, and inguinal lymph nodes. Other organs were rarely involved. At the time of diagnosis 50% of patients were in stage I, 21% in stage II, 22% in stage III, and 7% in stage IV. The prognosis was usually favorable or very favorable and depended on the stage of disease at diagnosis and on the age of the patient. Patients with stage I or III disease without splenic involvement had about the same probability of survival as the normal population. Stage III patients with splenic involvement had a lower probability of survival. The prognosis for stage II was also less favorable. Patients in stage IV had the lowest probability of survival. Closer analysis of the ten stage IV cases revealed two groups with different outcomes. Four cases showed progressive disease that did not respond to treatment and led to death within 12 months. The second, more favorable form (6 patients) responded well to chemotherapy. Nine patients in stage I who were not treated after lymph node biopsy were free of disease even after periods of up to 14 years. A total of 52 patients had one or more relapses. The recurrent tumors developed locally in a majority of cases. There was transformation of nodular paragranuloma into another subtype of Hodgkin's disease in only four cases. Five cases showed transformation into large-cell tumors that resembled immunoblastic lymphoma and require further immunological study.
Insights
Nodular paragranuloma, a subtype of Hodgkin's disease, predominantly affects males and has a favorable prognosis, especially in early stages. Treatment response and splenic involvement significantly impact survival rates.
Area of Science:
- Oncology
- Hematology
- Pathology
Background:
- Nodular paragranuloma is a subtype of lymphocyte predominance Hodgkin's disease.
- It exhibits a distinct clinical presentation and behavior compared to other Hodgkin's lymphoma subtypes.
Purpose of the Study:
- To investigate the clinical aspects of nodular paragranuloma.
- To analyze prognostic factors including stage, age, and splenic involvement.
- To examine treatment response and disease transformation patterns.
Main Methods:
- Retrospective analysis of 145 clinical cases of nodular paragranuloma.
- Evaluation of patient demographics, disease presentation, staging, treatment, and outcomes.
- Assessment of survival rates based on disease stage and patient age.
Main Results:
- Marked male predominance with a peak incidence in the 4th decade.
- Most frequent primary sites: cervical, axillary, and inguinal lymph nodes; B symptoms were rare.
- Favorable prognosis overall, strongly dependent on stage at diagnosis and age; early-stage disease without splenic involvement showed excellent survival.
- Stage IV disease showed varied outcomes, with some cases responding to chemotherapy and others progressing rapidly.
- Nine stage I patients treated with biopsy alone remained disease-free for up to 14 years.
- Relapses occurred locally in most cases; transformation to other Hodgkin's subtypes or large-cell tumors was infrequent.
Conclusions:
- Nodular paragranuloma generally has a favorable prognosis, particularly in early stages.
- Stage at diagnosis, age, and splenic involvement are critical prognostic indicators.
- Observation without immediate treatment may be a viable option for select early-stage patients.
- Understanding disease behavior and transformation is crucial for managing nodular paragranuloma.